Skip to main content

Table 5 Baseline characteristics of randomized participants

From: Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial

Baseline characteristics

Māori (n=257)

Non-Māori (n=256)

Total (n=513)

Number (%) or mean (SD)

Age (years)*

59 (8)

64 (8)

62 (8)

Women*

117 (46%)

70 (27%)

187 (36%)

History of CVD*

83 (32%)

150 (59%)

233 (45%)

Coronary artery disease*

60 (23%)

126 (49%)

186 (36%)

Cerebrovascular disease

22 (9%)

32 (13%)

54 (11%)

Peripheral vascular disease

9 (4%)

10 (4%)

19 (4%)

Diabetes*

124 (48%)

94 (37%)

218 (42%)

Type 1*

0

12 (5%)

12 (2%)

Type 2*

124 (48%)

82 (32%)

206 (40%)

Systolic blood pressure^ (mm Hg)

142 (21)

145 (19)

144 (20)

Diastolic blood pressure^ (mm Hg)*

85 (13)

81 (11)

83 (12)

Total cholesterol (mmol/l)*

4.60 (0.96)

4.21 (0.93)

4.41 (0.97)

LDL cholesterol (mmol/l)*

2.70 (0.85)

2.38 (0.78)

2.54 (0.83)

HDL cholesterol (mmol/l)

1.14 (0.26)

1.13 (0.30)

1.14 (0.28)

Total:HDL cholesterol ratio*

4.18 (1.08)

3.86 (0.96)

4.02 (1.05)

Triglycerides (mmol/l)*

1.70 (0.76)

1.54 (0.70)

1.62 (0.73)

  1. *Difference between Māori and non-Māori statistically significant, p<0.05.
  2. ^Measured using an automated blood pressure monitor (Omron T9P).